Please login to the form below

Not currently logged in
Email:
Password:

23andMe names privacy officer and corporate counsel

Kate Black joins from the US Department of Health and Human Services

edit-23andMe-Kate-BlackPersonal genetics firm 23andMe has appointed Kate Black as privacy officer and corporate counsel.

As a member of the legal and regulatory team, Black will be responsible for overseeing, updating and enhancing the company's privacy and consent policies for customers in the US and further afield.

Commenting on her appointment, Black said: “The potential impact that 23andMe can have on both individual health and the entire healthcare industry is profound.

“In appropriately leveraging the 23andMe database, we can significantly advance healthcare delivery, but we will not succeed unless we approach it with the utmost concern about protecting customer privacy and building customer trust.”

Black joins from the US Department of Health and Human Services, where she worked as a federal regulatory and interoperability policy analyst in the office of the national coordinator for health information technology.

She has also served as health privacy counsel for the Center for Democracy and Technology in San Francisco and has additionally worked on health technology policy initiatives at the Office of Science and Technology at the White House.

Kathy Hibbs, chief legal and regulatory affairs officer at 23andMe whom Black reports to, added: “Last year, our company committed to hiring a private officer to help us ensure that our privacy and consent policies best complement our philosophy on the importance of customer choice and empowerment.

“While we have always had a team dedicated to this effort, we are thrilled to have Kate take a leadership role at 23andMe.”

11th March 2015

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...

Latest intelligence

3 reasons why clinical trials will thrive in 2021
It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...

Infographics